• Home
  • Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis.

Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis.

Author List
Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, Cohen CR
Publication
Sexually transmitted diseases
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1469271
Publication Year
2009
PubMed ID
19543144
Publication Title
Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, Cohen CR. Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis. 2009 Sep; 36(9):564-9.